Kevin Norrett - 17 Nov 2025 Form 4 Insider Report for SOLENO THERAPEUTICS INC (SLNO)

Signature
/s/ Anish Bhatnagar, Attorney-in-Fact
Issuer symbol
SLNO
Transactions as of
17 Nov 2025
Net transactions value
$0
Form type
4
Filing time
19 Nov 2025, 18:49:51 UTC
Previous filing
07 Feb 2025
Next filing
23 Jan 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Norrett Kevin Chief Business Officer 100 MARINE PARKWAY, SUITE 400, REDWOOD CITY /s/ Anish Bhatnagar, Attorney-in-Fact 19 Nov 2025 0001819690

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLNO Common Stock Award $0 +14,286 $0.000000 14,286 17 Nov 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLNO Employee stock option (right to buy) Options Exercise $0 +64,286 $0.000000 64,286 17 Nov 2025 Common Stock 64,286 $47.25 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. One-half of the RSUs shall vest on November 17, 2026 and one third of the remaining RSUs shall vest each one-year anniversary thereafter, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2014 Equity Incentive Plan) through each such date.
F2 One-fourth of the shares subject to the option shall vest on November 17, 2026 and one forty-eighth of the shares subject to the option shall vest each month thereafter on the same day of the month, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2014 Equity Incentive Plan) through each such date.